A trader says he's sitting on a seven-figure profit from his Popcat long, despite the token still being down 77% from all-time highs. Multiple analysts forecast an imminent rally to $0.71-$1, citing explosive momentum and strong technical setups. Feel unsure about the market's next move?

The Latin American e-commerce and digital payments specialist reported stellar financial results.

Solidus Labs warns these mechanics are structurally predatory and may attract legal action from the DOJ or state prosecutors. Regulatory scrutiny is growing; a New York bill seeks to criminalize smart contract-based crypto scams like rug pulls. Feel unsure about the market's next move?

The Guiding and Establishing National Innovation for US Stablecoins of 2025 Act, known as the GENIUS Act, failed to pass cloture in the United States Senate on May 8, dealing a slight blow to cryptocurrency regulation in the country.The bill, sponsored by Senator Bill Hagerty and co-sponsored by ...

Dogecoin is trading higher by 11% Thursday afternoon. Global risk sentiment improves following the Trump administration's announcement of its first major trade agreement. Don't miss this list of 10 overlooked stocks-including one paying a 9% dividend-before Wall Street catches on.

After strong earnings and a Novo Nordisk tie-up, HIMS stock is squeezing bears hard with 33% of float shorted. With the stock up 96% in a month, technicals and short interest point to a potential short squeeze in motion.

Clean Harbors's CLH short percent of float has risen 28.69% since its last report. The company recently reported that it has 793 thousand shares sold short, which is 1.57% of all regular shares that are available for trading.

JBG SMITH Properties's JBGS short percent of float has fallen 3.31% since its last report. The company recently reported that it has 11.40 million shares sold short, which is 23.36% of all regular shares that are available for trading.

HubSpot's HUBS short percent of float has risen 25.45% since its last report. The company recently reported that it has 1.38 million shares sold short, which is 2.76% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.43 days to cover their ...

Looking into the current session, Bristol-Myers Squibb Inc. BMY shares are trading at $47.05, after a 1.20% decrease. Over the past month, the stock decreased by 6.76%, but over the past year, it actually spiked by 4.70%.